Send to

Choose Destination
High Blood Press Cardiovasc Prev. 2013 Jun;20(2):89-92. doi: 10.1007/s40292-013-0014-3. Epub 2013 May 8.

The use of the RESPeRATE device to lower blood pressure in inner city obese adolescents and children: a pilot feasibility study.

Author information

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94134, USA.


The RESPeRATE device was tested for feasibility of use in a population of overweight and obese children and adolescents (n = 10) in San Francisco, CA. After a 2-week and then a 2-month period, participants were interviewed on their frequency of use and attitudes towards the device. A high percentage stated that they enjoyed using the device at 2 months (90%) and 80% stated that they would recommend use to a friend or relative. Future studies are needed to assess the efficacy of the RESPeRATE device in lowering blood pressure and helping with weight loss/weight management in obese and overweight children.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center